Brenntag ETR: BNR reported a 41% year-over-year increase in second-quarter operating EBITDA to €463 million, citing stronger commercial execution, pricing discipline and accelerating savings from its cost-reduction program. Group revenue rose 11% to €4.3 billion, while operating gross profit increased nearly 19%.
Group CEO Jens Birgersson said the quarter marked a shift from a first quarter that was driven primarily by market volatility. In the second quarter, he said, results increasingly reflected the company’s own commercial initiatives, including customer penetration, cross-selling, upselling, pricing discipline and organizational simplification.
“The performance was broad-based across our businesses and regions,” Birgersson said. “We are now seeing the first tangible results from our strategic initiatives.”
Margins Expand as Essentials Leads Growth
Brenntag’s operating EBITDA conversion ratio reached about 40%, up roughly six percentage points from the prior-year period. CFO Thomas Reisten said gross margin expanded by 170 basis points to 27%, as the company captured pricing opportunities while maintaining commercial discipline.
The company’s Brenntag Essentials division was the largest contributor to the earnings increase. Operating EBITDA in Essentials rose 47% to €362 million, while sales grew 13% to €2.9 billion. Operating gross profit in the division increased 23%, and gross margin rose 2.2 percentage points to 28.5%.
Birgersson attributed the improvement partly to favorable pricing dynamics in indexed product categories, particularly oil-indexed products, as well as disciplined execution. Demand remained broadly stable, although customers continued to favor smaller orders and supply security, according to Reisten.
- Essentials operating EBITDA in EMEA rose 36% to €122 million.
- North America operating EBITDA increased 34% to €188 million.
- Latin America operating EBITDA more than doubled to €34 million.
- APAC operating EBITDA also more than doubled to €17 million.
Brenntag Specialties increased operating EBITDA 18% to €130 million, with sales up 6% to €1.3 billion. Operating gross profit in the division grew 9%, and gross margin improved 0.6 percentage points to 23.4%.
Within Specialties, Life Science generated operating EBITDA of €80 million, up 2% from a year earlier. Material Science operating EBITDA rose 71% to €51 million. The company said Material Science benefited from higher activity levels, pricing effects and growth across regions and businesses. Birgersson also pointed to strategic supplier partnerships and mandate expansions as factors supporting the business.
Cost-Savings Program Gains Momentum
The company generated €41 million in cost savings during the second quarter compared with its 2025 cost base, up from €27 million in the first quarter. Brenntag said the savings offset inflation, wage increases and higher transportation and energy costs, although Reisten said some of the benefit was also offset by higher bonus provisions and sales incentives tied to the stronger performance.
Brenntag is targeting approximately €150 million in gross savings in 2026 and cumulative savings of €200 million to €250 million by 2027, following a rebasing of the program to fiscal 2025. The company said the program is focused on organizational simplification, central-cost optimization and tighter management of discretionary spending.
Reisten said that, adjusted for the Middle East crisis and temporary increases in energy and transportation costs, close to half of the savings generated in the quarter flowed directly to the bottom line.
Cash Flow Declines on Working Capital Effects
Free cash flow was €4 million in the second quarter, compared with €154 million in the prior-year period. Management characterized the decline as technical and linked it to higher working-capital requirements from sales growth, seasonal effects and the upward revaluation of inventory at higher prices.
The company said the inventory effect did not reflect increased underlying inventory volumes. Higher sales also led to increased receivables and inventories, while trade payables rose alongside business activity. Brenntag said working-capital turnover reached 7.5 times in the quarter, exceeding both its year-end 2025 level and its first-half 2026 average. Reisten added that free cash flow was lowest in June and improved again in July.
Regional Conditions Remain Mixed; Outlook Raised
Brenntag said North American demand remained resilient and pricing held up better than expected, despite a more cautious customer environment. Latin America posted a strong quarter, with Mexico continuing to outperform as the Quimica Delta integration delivered expected synergies.
In EMEA, demand remained subdued, especially for industrial chemicals, and volumes were challenged. In APAC, the company cited continued pricing volatility, uneven demand and competitive pressure, including from Chinese suppliers seeking market share as domestic Chinese demand remained flat.
Management said geopolitical developments in the Middle East could continue to affect supply chains and logistics, while customer purchasing behavior remains cautious and oriented toward shorter order patterns. The company expects Material Science conditions to remain favorable in the second half, supported by construction-sector performance across most geographies.
Brenntag also said integration is progressing well for its recent Chem Tech Services acquisition in the U.S. and Airedale Group acquisition in the U.K. The company separately announced the acquisition of Woojin Trading, which expands its South Korean presence in the Beauty & Care market.
Following an encouraging start to the third quarter, Brenntag raised and narrowed its full-year 2026 operating EBITDA outlook to €1.35 billion to €1.45 billion, from its prior range of €1.25 billion to €1.4 billion. The company said volume trends at the start of the third quarter were broadly consistent with the second quarter, though it maintained caution because of limited market visibility and macroeconomic uncertainty.
Brenntag plans to host its 2026 Capital Markets Day on Nov. 12, where it said it will provide an update on strategic priorities, commercial initiatives, simplification efforts, digital capabilities and its next phase of transformation.
About Brenntag (ETR:BNR)
Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Germany, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber industries.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Brenntag, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brenntag wasn't on the list.
While Brenntag currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
